Cytodel, Inc. ® is a biopharmaceutical company that uses the tools of 21st-century molecular biology to produce recombinant derivatives of botulinum neurotoxin.

Biotechnology

Cytodel

Cytodel's headquarters in New York, NY, United States

Philip Band

Konstantin Ichtchenko

Gordon Beck

Steven Pal

Thomas Sudhof

Lawrence Remmel

André Gudger

Dennis Huang

Margery Fischbein

The Research and Development Team at Cytodel, Inc. focuses on innovating and refining recombinant derivatives of botulinum neurotoxin through cutting-edge molecular biology techniques. This team, comprised of researchers and medical consultants, collaborates to advance the efficacy and safety of biopharmaceutical products, driving the company’s commitment to breakthrough therapies in neurology and aesthetic medicine.

Research and Development Team

Cytodel

Org chart

Board & advisors

Teams

Research and Development Team

Offices

Cytodel

Org chart

Board & advisors

Teams

Research and Development Team

Offices

Related companies